Yupeng Li

Identification of GZD824 as an Orally Bioavailable Inhibitor That Targets Phosphorylated and Nonphosphorylated Breakpoint Cluster Region–Abelson (Bcr-Abl) Kinase and Overcomes Clinically Acquired Mutation-Induced Resistance against Imatinib

Xiaomei Ren, Xiaofen Pan, Zhang Zhang et al. · Journal of Medicinal Chemistry · 2013 · 174 citations · Full text

Nanoparticle‐Conjugate TLR7/8 Agonist Localized Immunotherapy Provokes Safe Antitumoral Responses

Lutz Nuhn, Stefaan De Koker, Sandra Van Lint et al. · Advanced Materials · 2018 · 157 citations

Integrated single-cell RNA sequencing analysis reveals distinct cellular and transcriptional modules associated with survival in lung cancer

Li Zhang, Yiming Zhang, Chengdi Wang et al. · Signal Transduction and Targeted Therapy · 2022 · 103 citations · Full text

Loss of eIF4E Phosphorylation Engenders Depression-like Behaviors via Selective mRNA Translation

Inês S. Amorim, Sonal Kedia, Stella Kouloulia et al. · Journal of Neuroscience · 2018 · 82 citations · Full text

Discovery of the First-in-Class Agonist-Based SOS1 PROTACs Effective in Human Cancer Cells Harboring Various KRAS Mutations

Chuan Zhou, Zisheng Fan, Zehui Zhou et al. · Journal of Medicinal Chemistry · 2022 · 77 citations · Full text